Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease = Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease

다국어 초록 (Multilingual Abstract)

Platelets are essential for progression of atherosclerotic lesions, plaque destabilization, and thrombosis. They secrete and express many substances that are crucial mediators of coagulation, inflammation, and atherosclerosis. Mean platelet volume (MPV) is a precise measure of platelet size, and is routinely reported during complete blood count analysis. Emerging evidence supports the use of MPV as a biomarker predicting the risk of ischemic stroke in patients with atrial fibrillation, and as a guide for prescription of anticoagulation and rhythm-control therapy. In addition, MPV may predict the clinical outcome of percutaneous coronary intervention (PCI) in patients with coronary artery disease and indicate whether additional adjunctive therapy is needed to improve clinical outcomes. This review focuses on the current evidence that MPV may be a biomarker of the risk and prognosis of common heart diseases, particularly atrial fibrillation and coronary artery disease treated via PCI.

참고문헌 (Reference)

1 송영희, "혈소판증가증 감별진단을 위한 ADVIA 120을 이용한 혈소판지수의 유용성 평가" 대한진단검사의학회 29 (29): 505-509, 2009

2 Bayar N, "Usefulness of mean platelet volume for predicting stroke risk in paroxysmal atrial fibrillation patients" 26 : 669-672, 2015

3 Turfan M, "Usefulness of mean platelet volume for predicting stroke risk in atrial fibrillation patients" 24 : 55-58, 2013

4 Goncalves SC, "Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention" 107 : 204-209, 2011

5 Ki YJ, "Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide" 25 : 427-432, 2014

6 Gasparyan AY, "The role of aspirin in cardiovascular prevention: implications of aspirin resistance" 51 : 1829-1843, 2008

7 Pabon Osuna P, "The effect of the mean platelet volume on the shortterm prognosis of acute myocardial infarct" 51 : 816-822, 1998

8 Brummitt DR, "The determination of a reference range for new platelet parameters produced by the Bayer ADVIA120 full blood count analyser" 22 : 103-107, 2000

9 Xu XF, "The association between mean platelet volume and chronic atrial fibrillation and the presence of thrombotic events" 3 : 388-394, 2015

10 Hong SP, "Stroke prevention in patients with non-valvular atrial fibrillation: new insight in selection of rhythm or rate control therapy and impact of mean platelet volume" 19 : 5824-5829, 2013

11 Ha SI, "Stroke prediction using mean platelet volume in patients with atrial fibrillation" 22 : 408-414, 2011

12 Wang XY, "Serial changes of mean platelet volume in relation to Killip Class in patients with acute myocardial infarction and primary percutaneous coronary intervention" 135 : 652-658, 2015

13 Tsadok MA, "Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation" 126 : 2680-2687, 2012

14 Hohnloser SH, "Rhythm or rate control in atrial fibrillation. Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial" 356 : 1789-1794, 2000

15 Maden O, "Relationship of admission hematological indexes with myocardial reperfusion abnormalities in acute ST segment elevation myocardial infarction patients treated with primary percutaneous coronary interventions" 25 : e164-e168, 2009

16 Koh YY, "Relation between the change in mean platelet volume and clopidogrel resistance in patients undergoing percutaneous coronary intervention" 13 : 687-693, 2015

17 Opolski G, "Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study" 126 : 476-486, 2004

18 Carlsson J, "Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study" 41 : 1690-1696, 2003

19 Rechcinski T, "Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention" 20 : 491-498, 2013

20 Seyyed-Mohammadzad MH, "Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention" 15 : 25-30, 2015

21 Akgul O, "Prognostic value of elevated mean platelet volume in patients undergoing primary angioplasty for ST-elevation myocardial infarction" 68 : 307-314, 2013

22 Price MJ, "Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation" 29 : 992-1000, 2008

23 Lekston A, "Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction" 28 : 652-657, 2014

24 Go AS, "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study" 285 : 2370-2375, 2001

25 Cakici M, "Predictors of thrombus burden and no-reflow of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of platelet indices" 25 : 709-715, 2014

26 Celik T, "Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction" 66 : 155-162, 2015

27 Patti G, "Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study" 52 : 1128-1133, 2008

28 Gawaz M, "Platelets in inflammation and atherogenesis" 115 : 3378-3384, 2005

29 Tsiara S, "Platelets as predictors of vascular risk: is there a practical index of platelet activity?" 9 : 177-190, 2003

30 Kim YG, "Platelet volume indices are associated with high residual platelet reactivity after antiplatelet therapy in patients undergoing percutaneous coronary intervention" 21 : 445-453, 2014

31 Bath PM, "Platelet size: measurement, physiology and vascular disease" 7 : 157-161, 1996

32 Cameron HA, "Platelet size in myocardial infarction" 287 : 449-451, 1983

33 Giles H, "Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction" 24 : 69-72, 1994

34 Shanker J, "Platelet function and antiplatelet therapy in cardiovascular disease:implications of genetic polymorphisms" 9 : 479-489, 2011

35 Kamath S, "Platelet activation: assessment and quantification" 22 : 1561-1571, 2001

36 Sherman DG, "Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study" 165 : 1185-1191, 2005

37 Michelson AD, "Methods for the measurement of platelet function" 103 (103): 20A-26A, 2009

38 Hart RG, "Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation" 146 : 857-867, 2007

39 Gasparyan AY, "Mean platelet volume: a link between thrombosis and inflammation?" 17 : 47-58, 2011

40 Kostrubiec M, "Mean platelet volume predicts early death in acute pulmonary embolism" 96 : 460-465, 2010

41 Huczek Z, "Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention" 46 : 284-290, 2005

42 Acar Z, "Mean platelet volume on admission is associated with further left ventricular functions in primary PTCA patients" 16 : 1567-1569, 2012

43 Pereg D, "Mean platelet volume on admission correlates with impaired response to thrombolysis in patients with ST-elevation myocardial infarction" 21 : 117-121, 2010

44 Providencia R, "Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation" 13 : 40-, 2013

45 Sarli B, "Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction" 24 : 285-289, 2013

46 Braekkan SK, "Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway" 8 : 157-162, 2010

47 Chu SG, "Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis" 8 : 148-156, 2010

48 Eisen A, "Mean platelet volume as a predictor for long-term outcome after percutaneous coronary intervention" 36 : 469-474, 2013

49 Shah B, "Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention" 111 : 185-189, 2013

50 Paulu P, "Lack of association between clopidogrel responsiveness tested using point of-care assay and prognosis of patients with coronary artery disease" 36 : 1-6, 2013

51 Greisenegger S, "Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?" 35 : 1688-1691, 2004

52 Moon AR, "High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for longterm clinical outcomes: a comparable and additive study" 27 : 70-76, 2016

53 Bonello L, "High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes" 58 : 467-473, 2011

54 Karpatkin S, "Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets" 48 : 1083-1087, 1969

55 Chugh SS, "Global burden of atrial fibrillation in developed and developing nations" 9 : 113-119, 2014

56 Tschoepe D, "Evidence for abnormal platelet glycoprotein expression in diabetes mellitus" 20 : 166-170, 1990

57 Duygu H, "Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris" 20 : 120-124, 2008

58 Karahan Z, "Effect of hematologic parameters on microvascular reperfusion in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention" 67 : 151-156, 2016

59 Kilicli-Camur N, "Could mean platelet volume be a predictive marker for acute myocardial infarction?" 11 : CR387-CR392, 2015

60 Snoep JD, "Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis" 154 : 221-231, 2007

61 Choi SW, "Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: implications of more simple and useful test than platelet function testing" 25 : 322-327, 2014

62 Coppinger JA, "Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions" 103 : 2096-2104, 2004

63 Martin JF, "Changes in volume and density of platelets in myocardial infarction" 287 : 456-459, 1983

64 Gillis AM, "Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management" 27 : 47-59, 2011

65 Seo HJ, "Brachial-ankle pulse wave velocity and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes in Korea: a comparable and additive study" 26 : 665-671, 2015

66 Collet JP, "Bedside monitoring to adjust antiplatelet therapy for coronary stenting" 367 : 2100-2109, 2012

67 Lai HM, "Association of mean platelet volume with impaired myocardial reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention" 27 : 5-12, 2016

68 Lai HM, "Association of mean platelet volume with angiographic thrombus burden and shortterm mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention" 85 (85): 724-733, 2015

69 Elbasan Z, "Association of mean platelet volume and pre- and postinterventional flow with infarct-related artery in ST-segment elevation myocardial infarction" 64 : 440-446, 2013

70 Sezer M, "Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention" 93 : 313-318, 2007

71 Leader A, "Are platelet volume indices of clinical use? A multidisciplinary review" 44 : 805-816, 2012

72 Van Gelder IC, "A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation" 347 : 1834-1840, 2002

73 Wyse DG, "A comparison of rate control and rhythm control in patients with atrial fibrillation" 347 : 1825-1833, 2002